CrossrefInfokarte
Comparative Outcomes of Generic and Branded Dasatinib in Chronic-Phase Chronic Myeloid Leukemia: A Single-Center Within-Patient Analysis
Journal of Blood Medicine · 2026-10 · Volume 17 · 1-12
DOI: 10.2147/jbm.s625380 ↗Abstract
Kein Abstract verfügbar.
EUVIMED